Latest Blogs

Feb 22, 2018
During a podcast interview on leadership and change, I had the opportunity to discuss how important ASCO is in the life of a cancer doctor.
Feb 22, 2018
Dr. Evgeniya Kharchenko dreamed of creating a local society for young specialists in Russia with ASCO’s values, and made her dream a reality.
Feb 22, 2018
Case-based presentations and tumor board discussions lend additional educational opportunities to this regional conference.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the delegate representing ASCO at the AMA-House of Delegates.

May 05, 2010
It seems like I've participated in every facet of the "ASCO guideline" process. During the past three years of being part of the HSC (now CPG) committee, I have been amazed to witness how complex and detailed developing a guideline can become. The manuscripts are reviewed at several levels and...

Pages